Post

Cybin completes dosing final cohort in MDD therapy trial

Cybin has completed dosing the final cohort in a Phase II study of CYB003 to treat moderate to severe major …

Aclaris finishes enrolment in atopic dermatitis Phase IIb trial of ATI-1777

Aclaris Therapeutics has concluded the enrolment of 250 patients in the Phase IIb ATI-1777-AD-202 study of ATI-1777 to treat mild …

Roche’s Evrysdi meets primary endpoint in trial for babies with SMA

Roche presented positive results from the Phase II Rainbowfish trial of Evrysdi (risdiplam) at the 28th World Muscle Society (WMS) …

Medable and Pluto Health partner to optimise clinical trials

Technology provider Medable has joined forces with Pluto Health, a care coordination services company, to improve and optimise access to …

Disc Medicine commences trial of DISC-3405 monoclonal antibody

Disc Medicine has commenced a Phase I study of the DISC-3405 monoclonal antibody in healthy volunteers. The single and multiple-ascending dose, …